Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-03-15 7:54 pm Purchase |
2021-03-03 | 13G | Millendo Therapeutics, Inc. MLND |
Citadel Advisors LLC | 61,777 4.900% |
61,777 (New Position) |
Filing History |
| 2021-03-15 4:42 pm Purchase |
2021-03-04 | 13G | FINTECH EVOLUTION ACQUI CORP U FTEVU |
Citadel Advisors LLC | 1,281,547 4.700% |
1,281,547 (New Position) |
Filing History |
| 2021-03-15 4:04 pm Purchase |
2021-03-05 | 13G | Priveterra Acquisition Corp. PMGM |
Citadel Advisors LLC | 1,396,871 5.100% |
1,396,871 (New Position) |
Filing History |
| 2021-03-12 4:02 pm Purchase |
2021-03-02 | 13G | IBERE PHARMACEUTICALS UNIT 1 C IBERU |
Citadel Advisors LLC | 776,710 5.600% |
776,710 (New Position) |
Filing History |
| 2021-03-08 4:01 pm Purchase |
2021-02-25 | 13G | Velocity Acquisition Corp. VELOU |
Citadel Advisors LLC | 1,699,966 7.400% |
1,699,966 (New Position) |
Filing History |
| 2021-03-01 4:01 pm Purchase |
2021-02-17 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 1,788,443 7.400% |
1,788,443 (New Position) |
Filing History |
| 2021-02-22 4:01 pm Purchase |
2021-02-10 | 13G | Genfit S.A. GNFT |
Citadel Advisors LLC | 462,177 1.200% |
462,177 (New Position) |
Filing History |
| 2021-02-19 4:03 pm Purchase |
2021-02-09 | 13G | Bolt Biotherapeutics, Inc. BOLT |
Citadel Advisors LLC | 2,942,007 8.100% |
2,942,007 (New Position) |
Filing History |
| 2021-02-18 4:01 pm Purchase |
2021-02-08 | 13G | Itiquira Acquisition Corp. ITQRU |
Citadel Advisors LLC | 1,150,662 5.000% |
1,150,662 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Applied Optoelectronics, Inc. AAOI |
Citadel Advisors LLC | 1,965,107 7.900% |
-115,842 (-5.57%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Citadel Advisors LLC | 364,785 2.100% |
-652,697 (-64.15%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Annexon, Inc. ANNX |
Citadel Advisors LLC | 2,136,115 5.600% |
15,782 (+0.74%) |
Filing History |
| 2021-02-16 4:30 pm Unchanged |
2020-12-31 | 13G | Spruce Biosciences, Inc. SPRB |
Citadel Advisors LLC | 1,701,787 7.300% |
0 (Unchanged) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Citadel Advisors LLC | 25,487 0.200% |
-512,178 (-95.26%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | CAPITOL INVT CORP V COM CAP |
Citadel Advisors LLC | 1,869,059 5.400% |
1,869,059 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Simplify China A Shares PLUS Income ETF CAS |
Citadel Advisors LLC | 1,250,082 5.400% |
1,250,082 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
Citadel Advisors LLC | 6,660,717 3.800% |
-2,234,718 (-25.12%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ |
Citadel Advisors LLC | 2,194,035 2.100% |
-1,198,589 (-35.33%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | AVROBIO, Inc. AVRO |
Citadel Advisors LLC | 139,068 4.000% |
-1,684 (-1.20%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | SuRo Capital Corp. SSSS |
Citadel Advisors LLC | 1,276,990 6.100% |
169,174 (+15.27%) |
Filing History |